A. J. Westermann, K. U. Förstner, F. Amman.,L.Barquist, Y.Chao, L.N. Schulte,L.Müller, R. Reinhardt,P. F. Stadler & J. Vogel. Nature (2016) doi:10.1038/nature16547
In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).
It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).